BELITE BIO INC - ADR (BLTE) Stock Income Statement
NASDAQ:BLTE - Nasdaq - US07782B1044 - ADR - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 31.67M | 12.82M | 9.80M | 5.74M | |||
| Research and Development | 24.84M | 8.87M | 7.42M | 3.69M | |||
| Selling, General, and Administrative Expenses | 6.82M | 3.95M | 2.38M | 2.06M | |||
| Operating Income | -31.67M | -12.82M | -9.80M | -5.74M | |||
| Interest Income/Expense | 45.00K | 170.00K | 130.00K | -10.00K | |||
| Income Before Taxes | -31.62M | -12.65M | -9.67M | -5.75M | |||
| Income Tax | 9.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -31.63M | -12.65M | -9.67M | -5.75M | |||
| EBITDA | -31.53M | -12.76M | -9.77M | -5.72M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.06 | -0.56 | -0.36 | -0.21 | |||
| Non GAAP EPS | -1.24 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD